SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-14-000352
Filing Date
2014-08-21
Accepted
2014-08-21 14:41:54
Documents
1
Group Members
DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 13 GP LTDNEA PARTNERS 13 L.P.PATRICK J. KERINSPETER J. BARRISRAVI VISWANATHANRYAN D. DRANTSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 EPIZYME, INC. epizyme-sch13d_17696.htm SC 13D/A 412880
  Complete submission text file 0001072613-14-000352.txt   414728
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) CIK: 0001452907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87481 | Film No.: 141057403
SIC: 2834 Pharmaceutical Preparations